{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:59:37Z","timestamp":1794653977890,"version":"4.9.1"},"reference-count":46,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"StatinTB clinical trial","award":["NCT04147286"],"award-info":[{"award-number":["NCT04147286"]}]},{"name":"European and Developing Countries Clinical Trials Partnership-2 (EDCTP2) program","award":["RIA2017T-2004-StatinTB"],"award-info":[{"award-number":["RIA2017T-2004-StatinTB"]}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203135\/Z\/16\/Z"],"award-info":[{"award-number":["203135\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background: Pulmonary inflammation is a widely recognized characteristic of active tuberculosis (TB). Although standard TB treatment is effective, a substantial proportion of mycobacteriologically cured TB patients experience persistent pulmonary inflammation, which can lead to long-term lung impairment, post-tuberculosis lung disease (PTLD) and potentially TB recurrence. Methods: We conducted a case\u2013control study to compare host serum biomarker profiles in individuals with minimal (TLG &lt; 50 SUVbw*mL, n = 37) versus extensive (TLG \u2265 50 SUVbw*mL, n = 34) persistent lung inflammation following completion of standard drug-sensitive TB treatment. Lung inflammation was measured by 18F-FDG PET\/CT scan using total lung glycolysis (TLG) as a surrogate marker. All participants had negative sputum cultures at four months of TB treatment, and blood samples were collected at treatment completion (month six). A Luminex\u00ae multiplex assay performed on the Bio-Plex\u00ae 200 platform was used to analyze 48 host serum biomarkers involved in cytokine\/chemokine signaling. Results: Following multiple t-test analysis, fifteen biomarkers were significantly elevated (p &lt; 0.05) in participants with extensive persistent lung inflammation compared to those with minimal inflammation. Among these, 14 demonstrated potential as discriminatory markers, with area under the curve (AUC) values ranging from 0.707 to 0.806, sensitivities ranging from 47.06% to 73.53%, and specificities ranging from 70.27% to 83.78%. Notably, 13 of these 16 candidate biomarkers significantly correlated with TLG values, further supporting their potential clinical utility. Conclusion: We report associations between serum inflammatory mediators and persistent pulmonary inflammation following mycobacterial clearance in TB patients, highlighting their potential as diagnostic biomarkers that could potentially meet the target product profile (TPP) criteria.<\/jats:p>","DOI":"10.3390\/diseases14020070","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:06:16Z","timestamp":1770905176000},"page":"70","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Host Serum Biomarker Signatures in Mycobacteriologically Cured Pulmonary Tuberculosis Patients with Persistent Lung Inflammation on 18F-FDG PET\/CT"],"prefix":"10.3390","volume":"14","author":[{"given":"Bongani","family":"Motaung","sequence":"first","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine (IDM), Department of Pathology, Division of Immunology, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa"},{"name":"International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, Cape Town 7925, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solima","family":"Sabeel","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine (IDM), Department of Pathology, Division of Immunology, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa"},{"name":"International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, Cape Town 7925, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9152-7614","authenticated-orcid":false,"given":"Mumin","family":"Ozturk","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine (IDM), Department of Pathology, Division of Immunology, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa"},{"name":"International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, Cape Town 7925, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor S.","family":"Mafu","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine (IDM), Department of Pathology, Division of Immunology, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa"},{"name":"International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, Cape Town 7925, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8776-4737","authenticated-orcid":false,"given":"Muki","family":"Shey","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa"},{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Mukasa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa"},{"name":"General Medicine & Global Health (GMGH), Cape Heart Institute, Faculty of Health Science, University of Cape Town, Cape Town 7925, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Wolmarans","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa"},{"name":"General Medicine & Global Health (GMGH), Cape Heart Institute, Faculty of Health Science, University of Cape Town, Cape Town 7925, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fareda","family":"Jakoet-Bassier","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa"},{"name":"General Medicine & Global Health (GMGH), Cape Heart Institute, Faculty of Health Science, University of Cape Town, Cape Town 7925, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashleigh","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa"},{"name":"General Medicine & Global Health (GMGH), Cape Heart Institute, Faculty of Health Science, University of Cape Town, Cape Town 7925, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoneta","family":"Mashinyira","sequence":"additional","affiliation":[{"name":"General Medicine & Global Health (GMGH), Cape Heart Institute, Faculty of Health Science, University of Cape Town, Cape Town 7925, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5362-1781","authenticated-orcid":false,"given":"Tessa","family":"Kotze","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa"},{"name":"Cape Universities Body Imaging Center (CUBIC), Department of Medicine, University of Cape Town, Cape Town 7925, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4801-2030","authenticated-orcid":false,"given":"Friedrich","family":"Thienemann","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa"},{"name":"General Medicine & Global Health (GMGH), Cape Heart Institute, Faculty of Health Science, University of Cape Town, Cape Town 7925, South Africa"},{"name":"Cape Universities Body Imaging Center (CUBIC), Department of Medicine, University of Cape Town, Cape Town 7925, South Africa"},{"name":"Department of Internal Medicine, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland"},{"name":"Department of Internal Medicine, Hirslanden AndreasKlinik Cham Zug, 6330 Cham Zug, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reto","family":"Guler","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine (IDM), Department of Pathology, Division of Immunology, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa"},{"name":"International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, Cape Town 7925, South Africa"},{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"220221","DOI":"10.1183\/16000617.0221-2022","article-title":"Post-tuberculosis lung impairment: Systematic review and meta-analysis of spirometry data from 14\u2009621 people","volume":"32","author":"Ivanova","year":"2023","journal-title":"Eur. Respir. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1159\/000512531","article-title":"Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge","volume":"100","author":"Allwood","year":"2021","journal-title":"Respiration"},{"key":"ref_3","unstructured":"WHO (2024). Global Tuberculosis Report 2024, World Health Organization."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2147\/COPD.S219731","article-title":"Transition from Restrictive to Obstructive Lung Function Impairment During Treatment and Follow-Up of Active Tuberculosis","volume":"15","author":"Allwood","year":"2020","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5588\/ijtldopen.23.0619","article-title":"Perspectives from the 2(nd) International Post-Tuberculosis Symposium: Mobilising advocacy and research for improved outcomes","volume":"1","author":"Allwood","year":"2024","journal-title":"IJTLD Open"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Kayongo, A., Nyiro, B., Siddharthan, T., Kirenga, B., Checkley, W., Lutaakome Joloba, M., Ellner, J., and Salgame, P. (2023). Mechanisms of lung damage in tuberculosis: Implications for chronic obstructive pulmonary disease. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1146571"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"110817","DOI":"10.1016\/j.cbi.2023.110817","article-title":"Post-tuberculosis lung disease and inflammatory role players: Can we characterise the myriad inflammatory pathways involved to gain a better understanding?","volume":"387","author":"Malefane","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"170077","DOI":"10.1183\/16000617.0077-2017","article-title":"Tuberculosis and lung damage: From epidemiology to pathophysiology","volume":"27","author":"Ravimohan","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Meghji, J., Simpson, H., Squire, S.B., and Mortimer, K. (2016). A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung Disease. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0161176"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"102244","DOI":"10.1016\/j.tube.2022.102244","article-title":"Immunologic and imaging signatures in post tuberculosis lung disease","volume":"136","author":"Singh","year":"2022","journal-title":"Tuberculosis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/nm.4177","article-title":"Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure","volume":"22","author":"Malherbe","year":"2016","journal-title":"Nat. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/S1473-3099(20)30148-1","article-title":"Cavitary tuberculosis: The gateway of disease transmission","volume":"20","author":"Urbanowski","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Sobic Saranovic, D., Vorster, M., Gambhir, S., and Pascual, T.N. (2020). FDG\u2013PET Imaging in TB: Patient Preparation and Imaging. PET\/CT in Tuberculosis, Springer International Publishing.","DOI":"10.1007\/978-3-030-47009-8"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13550-020-0591-9","article-title":"Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response","volume":"10","author":"Malherbe","year":"2020","journal-title":"EJNMMI Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/CM9.0000000000002771","article-title":"Post-tuberculosis lung disease and chronic obstructive pulmonary disease","volume":"136","author":"Gai","year":"2023","journal-title":"Chin. Med. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1473-3099(19)30518-3","article-title":"Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in Sao Paulo state, Brazil, 2010\u20132015: A population-based, longitudinal study","volume":"20","author":"Ranzani","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1378\/chest.06-2949","article-title":"Pulmonary impairment after tuberculosis","volume":"131","author":"Pasipanodya","year":"2007","journal-title":"Chest"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1172\/JCI12568","article-title":"Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis","volume":"107","author":"Kolb","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tube.2005.01.001","article-title":"Evaluating the role of tumor necrosis factor-alpha in experimental pulmonary tuberculosis in the guinea pig","volume":"85","author":"Lasco","year":"2005","journal-title":"Tuberculosis"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e2027754","DOI":"10.1001\/jamanetworkopen.2020.27754","article-title":"Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis","volume":"3","author":"Kumar","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Odia, T., Malherbe, S.T., Meier, S., Maasdorp, E., Kleynhans, L., du Plessis, N., Loxton, A.G., Zak, D.E., Thompson, E., and Duffy, F.J. (2021). The Peripheral Blood Transcriptome Is Correlated With PET Measures of Lung Inflammation During Successful Tuberculosis Treatment. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.596173"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"8629","DOI":"10.1038\/s41598-020-65043-8","article-title":"RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response","volume":"10","author":"Mbandi","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tube.2017.08.004","article-title":"Host blood RNA signatures predict the outcome of tuberculosis treatment","volume":"107","author":"Thompson","year":"2017","journal-title":"Tuberculosis"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Shang, P., Xia, Y., Liu, F., Wang, X., Yuan, Y., Hu, D., Tu, D., Chen, Y., Deng, P., and Cheng, S. (2011). Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0021836"},{"key":"ref_25","first-page":"e920350","article-title":"Drug-Induced Liver Injury from Anti-Tuberculosis Treatment: A Retrospective Cohort Study","volume":"26","author":"Zhao","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.5114\/aoms.2013.34403","article-title":"Distinctive biochemical changes in pulmonary tuberculosis and pneumonia","volume":"9","author":"Sahin","year":"2013","journal-title":"Arch. Med. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/0970-2113.53230","article-title":"Alkaline phosphatase: Distinguishing between tuberculous and nontuberculous pleural effusion","volume":"26","author":"Jadhav","year":"2009","journal-title":"Lung India"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.4102\/sajhivmed.v25i1.1558","article-title":"Management of drug-induced liver injury in people with HIV treated for tuberculosis: 2024 update","volume":"25","author":"Boyles","year":"2024","journal-title":"S. Afr. J. HIV Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ebiom.2017.10.018","article-title":"Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial","volume":"25","author":"Sigal","year":"2017","journal-title":"eBioMedicine"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ashenafi, S., Loreti, M.G., Bekele, A., Aseffa, G., Amogne, W., Kassa, E., Aderaye, G., and Brighenti, S. (2023). Inflammatory immune profiles associated with disease severity in pulmonary tuberculosis patients with moderate to severe clinical TB or anemia. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1296501"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"31798","DOI":"10.1038\/srep31798","article-title":"S100A12 is up-regulated in pulmonary tuberculosis and predicts the extent of alveolar infiltration on chest radiography: An observational study","volume":"6","author":"Goyal","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1155\/MI.2005.256","article-title":"Changes in serum cytokine levels in active tuberculosis with treatment","volume":"2005","author":"Deveci","year":"2005","journal-title":"Mediat. Inflamm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e34041","DOI":"10.1097\/MD.0000000000034041","article-title":"Interleukin-4 expression is increased in patients with tuberculosis: A systematic review and meta-analysis","volume":"102","author":"He","year":"2023","journal-title":"Medicine"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Nolan, A., Fajardo, E., Huie, M.L., Condos, R., Pooran, A., Dawson, R., Dheda, K., Bateman, E., Rom, W.N., and Weiden, M.D. (2013). Increased production of IL-4 and IL-12p40 from bronchoalveolar lavage cells are biomarkers of Mycobacterium tuberculosis in the sputum. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059461"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/315325","article-title":"Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities","volume":"181","author":"Karyadi","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Egholm, C., Heeb, L.E.M., Impellizzieri, D., and Boyman, O. (2019). The Regulatory Effects of Interleukin-4 Receptor Signaling on Neutrophils in Type 2 Immune Responses. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02507"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Zhang, H., Cao, X., Xin, H., Liu, J., Pan, S., Guan, L., Shen, F., Liu, Z., Wang, D., and Guan, X. (2020). Serum level of IL-1ra was associated with the treatment of latent tuberculosis infection in a Chinese population. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05047-x"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/jrms.JRMS_116_19","article-title":"The sequential assay of interleukin-10 and 13 serum levels in relation to radiographic changes during pulmonary tuberculosis treatment","volume":"25","author":"Moghaddam","year":"2020","journal-title":"J. Res. Med. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/clim.2002.5255","article-title":"Elevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosis","volume":"104","author":"Yamada","year":"2002","journal-title":"Clin. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Ren, X., Zhao, M., Lash, B., Martino, M.M., and Julier, Z. (2019). Growth Factor Engineering Strategies for Regenerative Medicine Applications. Front. Bioeng. Biotechnol., 7.","DOI":"10.3389\/fbioe.2019.00469"},{"key":"ref_41","first-page":"587","article-title":"Hepatocyte growth factor(HGF) in lung tuberculosis","volume":"71","author":"Imaizumi","year":"1996","journal-title":"Kekkaku"},{"key":"ref_42","first-page":"1189","article-title":"Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury","volume":"143","author":"Henke","year":"1993","journal-title":"Am. J. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1183\/09031936.00196412","article-title":"The fibroproliferative response in acute respiratory distress syndrome: Mechanisms and clinical significance","volume":"43","author":"Burnham","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.4049\/jimmunol.162.6.3549","article-title":"The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells","volume":"162","author":"Sauty","year":"1999","journal-title":"J. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Lombard, R., Doz, E., Carreras, F., Epardaud, M., Le Vern, Y., Buzoni-Gatel, D., and Winter, N. (2016). IL-17RA in Non-Hematopoietic Cells Controls CXCL-1 and 5 Critical to Recruit Neutrophils to the Lung of Mycobacteria-Infected Mice during the Adaptive Immune Response. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149455"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2249.2003.02121.x","article-title":"T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis","volume":"132","author":"Mazzarella","year":"2003","journal-title":"Clin. Exp. Immunol."}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/2\/70\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:42:03Z","timestamp":1770907323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/2\/70"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["diseases14020070"],"URL":"https:\/\/doi.org\/10.3390\/diseases14020070","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]}}}